Flow Traders U.S.’s Direxion Daily S&P Biotech Bear 3X ETF LABD Stock Holding History

Flow Traders U.S.’s Portfolio LABD Stock Details LABD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$117K	Buy	+15,164	New	+$204K	﹤0.01%	937
2022 Q1	–	Sell	-1,033	Closed	-$266K	–	910
2021 Q4	$266K	Buy	+1,033	New	+$238K	0.01%	644
2021 Q3	–	Sell	-2,080	Closed	-$401K	–	1098
2021 Q2	$401K	Buy	+2,080	New	+$466K	0.02%	651
2021 Q1	–	Sell	-4,920	Closed	-$1.24M	–	906
2020 Q4	$1.24M	Buy	+4,920	New	+$1.88M	0.09%	201
2020 Q3	–	Sell	-707	Closed	-$491K	–	588
2020 Q2	$491K	Buy	+707	New	+$888K	0.04%	294
2017 Q1	–	Sell	-4	Closed	-$154K	–	428
2016 Q4	$154K	Buy	+4	New	+$154K	0.01%	295
2016 Q3	–	Sell	-2	Closed	-$93.5K	–	373
2016 Q2	$122K	Sell	2 -22	-92%	-$1.77M	0.01%	205
2016 Q1	$2.5M	Buy	+24	New	+$3.07M	0.25%	58

Other funds holding LABD

BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

HRT Financial New York $54.8B AUM 81.03% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return

Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return

Squarepoint New York $90.5B AUM 33.95% 1-Year Est. Return

Ikarian Capital Dallas, Texas $928M AUM 596.14% 1-Year Est. Return

Jump Financial Chicago, Illinois $12.4B AUM 62.79% 1-Year Est. Return

XTX Topco George Town, Cayman Islands $7.72B AUM 32.88% 1-Year Est. Return

TSS

Two Sigma Securities New York $1.16B AUM 36.23% 1-Year Est. Return

Flow Traders U.S.'s LABD Position: Q2 2026 in Review

Flow Traders U.S. opened a new position in Direxion Daily S&P Biotech Bear 3X ETF (LABD) in Q2 2026: 15,164 shares worth $117K. The stake represents ﹤0.01% of the portfolio and ranks #937 among its holdings. This is a return to the name: Flow Traders U.S. previously reported a position in LABD as recently as Q4 2021.

Flow Traders U.S. first reported a position in LABD in Q1 2016 and has held it in 8 quarters since. The position peaked at $2.5M in Q1 2016. 21 funds tracked by Wall St. Rank hold LABD as of Q2 2026.

Flow Traders U.S. held 15,164 shares of Direxion Daily S&P Biotech Bear 3X ETF worth $117K as of Q2 2026.
Direxion Daily S&P Biotech Bear 3X ETF was a new Flow Traders U.S. position in Q2 2026.
Direxion Daily S&P Biotech Bear 3X ETF made up ﹤0.01% of Flow Traders U.S.'s portfolio in Q2 2026, its #937 holding.
Flow Traders U.S. first reported a position in Direxion Daily S&P Biotech Bear 3X ETF in Q1 2016 and has held it in 8 quarters since.
Flow Traders U.S.'s Direxion Daily S&P Biotech Bear 3X ETF position peaked at $2.5M in Q1 2016.
21 funds tracked by Wall St. Rank held Direxion Daily S&P Biotech Bear 3X ETF as of Q2 2026.

Based on Flow Traders U.S.'s 13F filing for Q2 2026, filed 14 Aug 2026.